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The emergence of multidrug resistance in bacteria is a rising global threat, as pathogenic strains of bacteria have evaded treatments to currently available antibiotics. A way to combat this rising
antibiotic resistance is to develop novel inhibitory compounds targeting an established bacterial enzyme that is essential for bacterial survival. Thus, the significance of our research is underscored
by the enzyme, N-succinyl-L,L-diaminopimelic acid desuccinylase, abbreviated DapE, which is found in the lysine biosynthetic pathway of all gram negative and most gram positive species of bacteria.
DapE catalyzes a reaction that yields a precursor for the synthesis of m-DAP and lysine, which are ultimately recruited for bacterial cell walls. Due to the absence of the lysine biosynthetic pathway in
mammals, DapE inhibitors are expected to exhibit high selectivity for bacteria, eliminating mechanism-based toxicity in humans. A high-throughput screening (HiTS) of molecule interactions with
DapE was performed to identify candidates that could act as potential DapE inhibitors. Three-point modifications were made to the functional group moieties of one of the original hit-derived lead
molecules, a tetrazole thioether, in order to synthesize a diverse library of novel analog inhibitor compounds with improved potency and efficacy against DapE. These newly synthesized inhibitors
will then be tested and analyzed by our ninhydrin-based enzymatic assay to determine their overall effect on DapE inhibition.

Introduction
DapE is an essential bacterial enzyme in the biosynthetic
pathway responsible for the production of mesodiaminopimelic acid (m-DAP) and the amino acid lysine,
which are crucial precursors in bacterial cell wall synthesis.
DapE catalyzes the hydrolysis of of N-succinyl-L,Ldiaminopimelic acid (L,L-SDAP) to succinic acid and L,Ldiaminopimelate (DAP). DAP will then act as the precursor to
form m-DAP which is then converted to lysine (Scheme 1).1
The lack of a similar pathway in the human body makes DapE
an attractive drug target because inhibitors of DapE will be
selective for bacterial strains without the threat of
mechanism-based toxicity in humans.2 DapE is a di-metallo
homodimer enzyme with a catalytic and dimerization domain
in each subunit. The active binding site is located in the
catalytic domain consisting of a di-zinc metal center. DapE
exists in both open and closed conformations, which is
modulated by substrate binding utilizing both catalytic and
dimerization domains (Figure 1).3

Figure 3. Plausible point derivations Figure 4. Plausible point derivations of
the analogous pyrazole scaffold.
of tetrazole scaffold.

In order to improve the potency of the lead molecule against DapE,
three point derivatizations were made to the tetrazole thioether at
locations R1, R2, R3, and R4 (Figure 3).5 Driving the structure activity
relationship, the modifications at these sites will be accomplished
specifically by adding various substituents such as hydrogen or a
methyl group to the R2 position, alkyl groups at the R3 position, and
alkyl, aryl, heteroaryl, aralkyl, and heteroaralkyl compounds to the
R4 position to investigate their effects on the enzyme active site
binding. In parallel, I have also been working on making these same
modifications utilizing a pyrazole (Figure 4), which is a tetrazole
bioisostere. The same synthetic route and conditions were used to
prepare both the tetrazole thioether and pyrazole thioether
analogs as seen in the schemes below.

Scheme 1. Hydrolysis of L,L-SDAP to
Succinate and DAP by the enzyme DapE

.

Figure 1. Open and closed
conformations of DapE enzyme

.

Objectives
A high-throughput screening (HiTS) was performed to identify
lead molecules in designing potent DapE inhibitors. This project
focuses on developing analogs of the tetrazole thioether
original hit (Figure 2.) and obtaining its inhibitory potencies of
analogs synthesized. To further improve the potency of the hitderived tetrazole analogs, structure-activity relationships (SAR)
will be utilized along with molecular docking using Molecular
Operating Environment (MOE). The docking results will predict
the interactions between the inhibitor molecules and the active
site residues along with the di-zinc center of the DapE enzyme.
The IC50 values of the newly synthesized inhibitors against DapE
will be obtained via the ninhydrin-based biochemical assay
developed in the Becker lab.4

Figure 2. DapE tetrazole thioether HiTS
obtained lead molecule.

Results

Methodology

Scheme 2. Synthesis of tetrazole thioether derivatives.
Reagents and Conditions: a) potassium carbonate, dichloromethane, rt, overnight;
b) potassium carbonate, acetone reflux, 1h.6

Figure 5. Derivatized tetrazole and pyrazole thioether analogs.

I have successfully synthesized these four
compounds above and confirmed them with an
HPLC Purity of > 95%, 1H NMR and13C NMR. These
compounds are awaiting testing against DapE in our
Ninhydrin-Based Assay.

Conclusion & Future Plans
The next steps for this project include analyzing the
assay data to determine if these newly synthesized
compounds demonstrate greater inhibition than the
original lead molecule. We will then further oxidize
the most potent compounds synthesized in Figure 5,
into sulfones, to create a new series. We also plan to
explore the synthesis of N-linked pyrazole and
tetrazole analogs, to hopefully create a more diverse
library of novel analog inhibitors with improved
potency and efficacy against DapE will be assembled.
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